Showing results (1-10 of 130) with videos related to
Sort By:
Pageof 13
Drugs|January 1, 1988
The future of pharmacological therapy for risk factor reduction. HyperlipidaemiaA G Olsson, J MölgaardAtherosclerosis|December 1, 1991
Plasma high density lipoprotein particle size alteration by simvastatin treatment in patients with hypercholesterolaemiaJ Johansson, J Mölgaard, A G OlssonVASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1996
Copper-induced low density lipoprotein oxidation is not a risk discriminator for intermittent claudicationB Ziedén, J Mölgaard, A G OlssonEuropean Journal of Clinical Pharmacology|January 1, 1989
Comparative effects of simvastatin and cholestyramine in treatment of patients with hypercholesterolaemiaJ Mölgaard, H von Schenck, A G OlssonEuropean Heart Journal|May 1, 1988
Effects of simvastatin on plasma lipid, lipoprotein and apolipoprotein concentrations in hypercholesterolaemiaJ Mölgaard, H von Schenck, A G OlssonThe American Journal of Cardiology|April 6, 1999
Efficacy and safety of simvastatin for high-risk hypercholesterolemiaJ Mölgaard, S Wärjerstam-Elf, A G OlssonAtherosclerosis|May 1, 1987
Alfalfa seeds lower low density lipoprotein cholesterol and apolipoprotein B concentrations in patients with type II hyperlipoproteinemiaJ Mölgaard, H von Schenck, A G OlssonJournal of Internal Medicine|May 1, 1990
Decreased mitogenic activity in hypercholesterolaemic plasmaJ Mölgaard, M Carlsson, J Nilsson, et al.Atherosclerosis|December 1, 1991
Long-term efficacy and safety of simvastatin alone and in combination therapy in treatment of hypercholesterolaemiaJ Mölgaard, B L Lundh, H von Schenck, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|July 1, 1995
Predilection of atherosclerosis for the inner curvature in the femoral artery. A digitized angiography studyO Smedby, J Johansson, J Mölgaard, et al.Pageof 13